Let's break down the importance of its Amazon deal and analyze what the business is still struggling with to ... But an even ...

Gilead Sciences’ Kite Pharma will sell its stake in China’s Fosun Kite Biotechnology nearly eight years after forming the ...

Achilles Therapeutics (ACHL) stock surges as company announces plans to explore strategic alternatives. Read more here.

Rocket Pharmaceuticals announced enrollment completion for phase 2 study using its gene therapy RP-A501 for treatment of male ...

Coeptis Therapeutics Holdings, Inc. (Nasdaq: COEP) (the "Company" or "Coeptis"), a biopharmaceutical company developing innovative cell therapy platforms for cancer, autoimmune, and infectious ...

BriaCell Therapeutics recently closed an $8.5 million stock sale after its positive results from mid-stage testing of its ...

D Molecular Therapeutics (FDMT – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst yesterday.

Vanda pharmeucitals received a rejection for its drug tradipitant, causing the company management to criticize the FDA.

CYB003: A proprietary deuterated psilocin program with FDA Breakthrough Therapy ... its business, it may have a material adverse effect on Cybin’s performance and operations. Neither the Cboe Canada ...

Clinical trial results suggest that it can reduce symptoms more quickly and effectively than sebetralstat, another oral therapy. Furthermore ... Morgan Stanley also maintained a Buy rating on the ...

BDX launches the Neopak XtraFlow Glass Prefillable Syringe, enhancing drug delivery for biologics and expanding capacity with ...

Pengana High Conviction Equities Fund portfolio manager James McDonald reckons these three biotechs are primed for growth.